{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:21:19Z","timestamp":1792905679688,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005153","name":"China National Funds for Distinguished Young Scientists","doi-asserted-by":"publisher","award":["82025022"],"award-info":[{"award-number":["82025022"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151212"],"award-info":[{"award-number":["82151212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101857"],"award-info":[{"award-number":["82101857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["KQTD20200909113758004"],"award-info":[{"award-number":["KQTD20200909113758004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2021B1212030010"],"award-info":[{"award-number":["2021B1212030010"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Central Charity Fund of Chinese Academy of Medical Science"},{"name":"the National key research and development program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a global pandemic that seriously threatens health and socioeconomic development, but the existed antiviral drugs and vaccines still cannot yet halt the spread of the epidemic. Therefore, a comprehensive and profound understanding of the pathogenesis of SARS-CoV-2 is urgently needed to explore effective therapeutic targets. Here, we conducted a multiomics study of SARS-CoV-2-infected lung epithelial cells, including transcriptomic, proteomic, and ubiquitinomic. Multiomics analysis showed that SARS-CoV-2-infected lung epithelial cells activated strong innate immune response, including interferon and inflammatory responses. Ubiquitinomic further reveals the underlying mechanism of SARS-CoV-2 disrupting the host innate immune response. In addition, SARS-CoV-2 proteins were found to be ubiquitinated during infection despite the fact that SARS-CoV-2 itself didn\u2019t code any E3 ligase, and that ubiquitination at three sites on the Spike protein could significantly enhance viral infection. Further screening of the E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) library revealed four E3 ligases influencing SARS-CoV-2 infection, thus providing several new antiviral targets. This multiomics combined with high-throughput screening study reveals that SARS-CoV-2 not only modulates innate immunity, but also promotes viral infection, by hijacking ubiquitination-specific processes, highlighting potential antiviral and anti-inflammation targets.<\/jats:p>","DOI":"10.1038\/s41392-022-01156-y","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:05:14Z","timestamp":1662548714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0687-8108","authenticated-orcid":false,"given":"Gang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-1389","authenticated-orcid":false,"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"1156_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842\u2013844 (2020).","journal-title":"Nat. Med."},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41421-020-00225-2","volume":"6","author":"G Xu","year":"2020","unstructured":"Xu, G. et al. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov. 6, 73 (2020).","journal-title":"Cell Discov."},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"816745","DOI":"10.3389\/fimmu.2021.816745","volume":"12","author":"G Xu","year":"2021","unstructured":"Xu, G. et al. The transient IFN response and the delay of adaptive immunity feature the severity of COVID-19. Front. Immunol. 12, 816745 (2021).","journal-title":"Front. Immunol."},{"key":"1156_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","volume":"182","author":"M Bouhaddou","year":"2020","unstructured":"Bouhaddou, M. et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685\u2013712.e619 (2020).","journal-title":"Cell"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-021-03493-4","volume":"594","author":"A Stukalov","year":"2021","unstructured":"Stukalov, A. et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature 594, 246\u2013252 (2021).","journal-title":"Nature"},{"key":"1156_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.molcel.2020.11.028","volume":"80","author":"RM Hekman","year":"2020","unstructured":"Hekman, R. M. et al. Actionable cytopathogenic host responses of human alveolar type 2 cells to SARS-CoV-2. Mol. Cell 80, 1104\u20131122.e1109 (2020).","journal-title":"Mol. Cell"},{"key":"1156_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469\u2013472 (2020).","journal-title":"Nature"},{"key":"1156_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen, B. et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59\u201372.e15 (2020).","journal-title":"Cell"},{"key":"1156_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","volume":"184","author":"X Nie","year":"2021","unstructured":"Nie, X. et al. Multi-organ proteomic landscape of COVID-19 autopsies. Cell 184, 775\u2013791.e714 (2021).","journal-title":"Cell"},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem"},{"key":"1156_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.cell.2016.02.019","volume":"164","author":"K Rajalingam","year":"2016","unstructured":"Rajalingam, K. & Dikic, I. SnapShot: expanding the ubiquitin code. Cell 164, 1074\u20131074.e1071 (2016).","journal-title":"Cell"},{"key":"1156_CR13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05732","volume":"446","author":"MU Gack","year":"2007","unstructured":"Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916\u2013920 (2007).","journal-title":"Nature"},{"key":"1156_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19318-3","volume":"11","author":"ZD Zhang","year":"2020","unstructured":"Zhang, Z. D. et al. RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA. Nat. Commun. 11, 5536 (2020).","journal-title":"Nat. Commun."},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1016\/j.cell.2021.04.047","volume":"184","author":"W Fan","year":"2021","unstructured":"Fan, W. et al. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell 184, 3410\u20133425.e3417 (2021).","journal-title":"Cell"},{"key":"1156_CR16","doi-asserted-by":"publisher","first-page":"e1006542","DOI":"10.1371\/journal.ppat.1006542","volume":"13","author":"XJ Liu","year":"2017","unstructured":"Liu, X. J. et al. Human cytomegalovirus IE1 downregulates Hes1 in neural progenitor cells as a potential E3 ubiquitin ligase. PLoS Pathog. 13, e1006542 (2017).","journal-title":"PLoS Pathog."},{"key":"1156_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/s41422-021-00578-7","volume":"31","author":"G Xu","year":"2021","unstructured":"Xu, G. et al. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation. Cell Res. 31, 1230\u20131243 (2021).","journal-title":"Cell Res."},{"key":"1156_CR18","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. The architecture of SARS-CoV-2 transcriptome. Cell 181, 914\u2013921.e910 (2020).","journal-title":"Cell"},{"key":"1156_CR19","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045.e1039 (2020).","journal-title":"Cell"},{"key":"1156_CR20","doi-asserted-by":"publisher","first-page":"9581","DOI":"10.1073\/pnas.1604277113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation. Proc. Natl Acad. Sci. USA 113, 9581\u20139586 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1156_CR21","doi-asserted-by":"crossref","unstructured":"Yoo, Y. S. et al. The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling. Nat. Commun. 6, 7910 (2015).","DOI":"10.1038\/ncomms8910"},{"key":"1156_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-10-44","volume":"10","author":"C Castanier","year":"2012","unstructured":"Castanier, C. et al. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol. 10, 44 (2012).","journal-title":"BMC Biol."},{"key":"1156_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.celrep.2013.01.033","volume":"3","author":"D Tu","year":"2013","unstructured":"Tu, D. et al. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 3, 747\u2013758 (2013).","journal-title":"Cell Rep."},{"key":"1156_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jmcb\/mjr020","volume":"3","author":"Y Ran","year":"2011","unstructured":"Ran, Y. et al. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation. J. Mol. Cell Biol. 3, 283\u2013292 (2011).","journal-title":"J. Mol. Cell Biol."},{"key":"1156_CR25","doi-asserted-by":"publisher","first-page":"e1004726","DOI":"10.1371\/journal.ppat.1004726","volume":"11","author":"P Wang","year":"2015","unstructured":"Wang, P., Zhao, W., Zhao, K., Zhang, L. & Gao, C. TRIM26 negatively regulates interferon-beta production and antiviral response through polyubiquitination and degradation of nuclear IRF3. PLoS Pathog. 11, e1004726 (2015).","journal-title":"PLoS Pathog."},{"key":"1156_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14948-z","volume":"11","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. Nat. Commun. 11, 1146 (2020).","journal-title":"Nat. Commun."},{"key":"1156_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29442-x","volume":"13","author":"G Apriamashvili","year":"2022","unstructured":"Apriamashvili, G. et al. Ubiquitin ligase STUB1 destabilizes IFNgamma-receptor complex to suppress tumor IFNgamma signaling. Nat. Commun. 13, 1923 (2022).","journal-title":"Nat. Commun."},{"key":"1156_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19935-y","volume":"11","author":"X Li","year":"2020","unstructured":"Li, X. et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat. Commun. 11, 6364 (2020).","journal-title":"Nat. Commun."},{"key":"1156_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24521-x","volume":"12","author":"R Robinot","year":"2021","unstructured":"Robinot, R. et al. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat. Commun. 12, 4354 (2021).","journal-title":"Nat. Commun."},{"key":"1156_CR30","doi-asserted-by":"crossref","unstructured":"Casorla-Perez, L. A., Lopez, T., Lopez, S. & Arias, C. F. The ubiquitin-proteasome system is necessary for efficient replication of human astrovirus. J. Virol. 92, e01809\u201317 (2018).","DOI":"10.1128\/JVI.01809-17"},{"key":"1156_CR31","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1128\/JVI.00485-10","volume":"84","author":"M Raaben","year":"2010","unstructured":"Raaben, M. et al. The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J. Virol. 84, 7869\u20137879 (2010).","journal-title":"J. Virol."},{"key":"1156_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.chom.2014.03.002","volume":"15","author":"G Chen","year":"2014","unstructured":"Chen, G., Liu, C. H., Zhou, L. & Krug, R. M. Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein. Cell Host Microbe 15, 484\u2013493 (2014).","journal-title":"Cell Host Microbe"},{"key":"1156_CR33","doi-asserted-by":"crossref","unstructured":"Cai, Z. et al. USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2. J. Exp. Med. 217, e20191174 (2020).","DOI":"10.1084\/jem.20191174"},{"key":"1156_CR34","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/15384101.2016.1160972","volume":"15","author":"M Toompuu","year":"2016","unstructured":"Toompuu, M., Karblane, K., Pata, P., Truve, E. & Sarmiento, C. ABCE1 is essential for S phase progression in human cells. Cell Cycle 15, 1234\u20131247 (2016).","journal-title":"Cell Cycle"},{"key":"1156_CR35","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/onc.2011.48","volume":"30","author":"G Donati","year":"2011","unstructured":"Donati, G. et al. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene 30, 3274\u20133288 (2011).","journal-title":"Oncogene"},{"key":"1156_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"1156_CR37","unstructured":"Gordon, D. E. et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science 370, eabe9403 (2020)."},{"key":"1156_CR38","first-page":"99","volume":"2","author":"J Li","year":"2021","unstructured":"Li, J. et al. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med (N. Y) 2, 99\u2013112.e117 (2021).","journal-title":"Med (N. Y)"},{"key":"1156_CR39","doi-asserted-by":"publisher","unstructured":"May, D. G. et al. A BioID-derived proximity interactome for SARS-CoV-2 proteins. Viruses 14 https:\/\/doi.org\/10.1101\/2021.09.17.460814 (2022).","DOI":"10.1101\/2021.09.17.460814"},{"key":"1156_CR40","doi-asserted-by":"publisher","unstructured":"Payman, H. A. et al. A SARS-CoV-2\u2013host proximity interactome. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.09.03.282103 (2020).","DOI":"10.1101\/2020.09.03.282103"},{"key":"1156_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41392-021-00651-y","volume":"6","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity. Signal Transduct. Target Ther. 6, 231 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1156_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/boc.201200006","volume":"104","author":"M Veit","year":"2012","unstructured":"Veit, M. Palmitoylation of virus proteins. Biol. Cell 104, 493\u2013515 (2012).","journal-title":"Biol. Cell"},{"key":"1156_CR43","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41423-020-0514-8","volume":"17","author":"HW Jiang","year":"2020","unstructured":"Jiang, H. W. et al. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell Mol. Immunol. 17, 998\u20131000 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"1156_CR44","doi-asserted-by":"crossref","unstructured":"Puthenveetil, R. et al. S-acylation of SARS-CoV-2 spike protein: mechanistic dissection, in vitro reconstitution and role in viral infectivity. J. Biol. Chem. 297, 101112 (2021).","DOI":"10.1016\/j.jbc.2021.101112"},{"key":"1156_CR45","doi-asserted-by":"crossref","unstructured":"Tian, W. et al. O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an \u201cO-Follow-N\u201d rule. Cell Res. 31, 1123\u20131125 (2021).","DOI":"10.1038\/s41422-021-00545-2"},{"key":"1156_CR46","doi-asserted-by":"crossref","unstructured":"Lun, C. M., Waheed, A. A., Majadly, A., Powell, N. & Freed, E. O. Mechanism of viral glycoprotein targeting by membrane-associated RING-CH proteins. mBio 12, e00219\u201321 (2021).","DOI":"10.1128\/mBio.00219-21"},{"key":"1156_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.2229","volume":"13","author":"N Yan","year":"2012","unstructured":"Yan, N. & Chen, Z. J. Intrinsic antiviral immunity. Nat. Immunol. 13, 214\u2013222 (2012).","journal-title":"Nat. Immunol."},{"key":"1156_CR48","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","volume":"295","author":"U Felgenhauer","year":"2020","unstructured":"Felgenhauer, U. et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J. Biol. Chem. 295, 13958\u201313964 (2020).","journal-title":"J. Biol. Chem."},{"key":"1156_CR49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1089\/jir.2020.0214","volume":"40","author":"H Xia","year":"2020","unstructured":"Xia, H. & Shi, P. Y. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2. J. Interferon Cytokine Res. 40, 543\u2013548 (2020).","journal-title":"J. Interferon Cytokine Res."},{"key":"1156_CR50","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia, H. et al. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 33, 108234 (2020).","journal-title":"Cell Rep."},{"key":"1156_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei, X. et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3810 (2020).","journal-title":"Nat. Commun."},{"key":"1156_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.chom.2009.04.006","volume":"5","author":"MU Gack","year":"2009","unstructured":"Gack, M. U. et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439\u2013449 (2009).","journal-title":"Cell Host Microbe"},{"key":"1156_CR53","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","volume":"193","author":"CS Shi","year":"2014","unstructured":"Shi, C. S. et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome. J. Immunol. 193, 3080\u20133089 (2014).","journal-title":"J. Immunol."},{"key":"1156_CR54","doi-asserted-by":"publisher","first-page":"e5760","DOI":"10.1371\/journal.pone.0005760","volume":"4","author":"D Gao","year":"2009","unstructured":"Gao, D. et al. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS ONE 4, e5760 (2009).","journal-title":"PLoS ONE"},{"key":"1156_CR55","doi-asserted-by":"publisher","first-page":"e1003533","DOI":"10.1371\/journal.ppat.1003533","volume":"9","author":"H Oshiumi","year":"2013","unstructured":"Oshiumi, H., Miyashita, M., Matsumoto, M. & Seya, T. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9, e1003533 (2013).","journal-title":"PLoS Pathog."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01156-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:41:50Z","timestamp":1664973710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01156-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01156-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}